EIM
STIM icon

Essex Investment Management’s Neuronetics STIM Stock Holding History

Essex Investment Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-82,668
Closed -$149K – 325
2024
Q2 		$149K Buy
+82,668
New +$238K 0.03% 205
2021
Q3 		– Sell
-190,163
Closed -$3.05M – 439
2021
Q2 		$3.05M Buy
190,163
+27,801
+17% +$384K 0.35% 95
2021
Q1 		$2.01M Buy
162,362
+28,065
+21% +$430K 0.24% 140
2020
Q4 		$1.49M Buy
+134,297
New +$1.01M 0.19% 174

Other funds holding STIM

KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Essex Investment Management's STIM Position: Q3 2024 in Review

Essex Investment Management sold out of Neuronetics (STIM) in Q3 2024, closing a stake of 82,668 shares — an estimated $149K sold.

Essex Investment Management first reported a position in STIM in Q4 2020 and held it in 4 quarters. The position peaked at $3.05M in Q2 2021. 48 funds tracked by Wall St. Rank hold STIM as of Q3 2024.

  • Essex Investment Management reported no remaining Neuronetics position as of Q3 2024 after selling out during the quarter.
  • Essex Investment Management sold 82,668 Neuronetics shares in Q3 2024, an estimated $149K.
  • Essex Investment Management first reported a position in Neuronetics in Q4 2020 and held it in 4 quarters.
  • Essex Investment Management's Neuronetics position peaked at $3.05M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Neuronetics as of Q3 2024.

Based on Essex Investment Management's 13F filing for Q3 2024, filed 10 Oct 2024.